V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004855 | 330002343 | 1.78 | null | Curative (C) | 2013-06-03 | 2013-06-03 | CHLORAMBUCIL + RITUXIMAB | null | N | 330020510 | DOXORUBICIN + IFOSFAMIDE |
| 330004856 | 330002344 | 1.7 | 62 | Curative (C) | 2017-01-22 | 2017-01-22 | TEMOZOLOMIDE | 02 | N | 330020512 | CAPECITABINE + CISPLATIN |
| 330004857 | 330007290 | 1.68 | 94.4 | Palliative (P) | 2014-10-19 | 2014-10-20 | Cytarabine Low Dose | N | N | 330020518 | CARBOPLATIN + RT |
| 330004858 | 330002345 | 1.67 | 79.9 | Palliative (P) | 2015-06-04 | 2015-08-13 | FLAG + Idarubicin | N | N | 330020519 | MITOTANE |
| 330004859 | 330002346 | 1.67 | 66.8 | Not known (9) | 2013-06-23 | 2013-06-23 | Mitotane 2g | 01 | N | 330020525 | CARBOPLATIN + RT |
| 330004860 | 330002347 | 1.8 | 90.4 | Curative (C) | 2015-09-22 | 2015-09-22 | AML 18 TRIAL | 02 | N | 330020527 | DOXORUBICIN + IFOSFAMIDE |
| 330004861 | 330002347 | 1.65 | null | Palliative (P) | null | 2015-07-27 | Capecitabine (21days) + Carboplatin | null | null | 330020527 | CISPLATIN + VINORELBINE |
| 330004862 | 330002347 | 1.65 | 87.3 | Curative (C) | 2014-08-10 | 2014-08-15 | DAUNORUBICIN + VINCRISTINE | 02 | null | 330020527 | DOXORUBICIN + IFOSFAMIDE |
| 330004863 | 330002347 | 0 | 66 | Palliative (P) | 2016-03-22 | 2016-04-01 | Azacitidine | 2 | N | 330020527 | CAPECITABINE + IRINOTECAN |
| 330004864 | 330002347 | 1.67 | 55.5 | Palliative (P) | 2014-06-04 | 2014-06-05 | ATG + Busulfan + Fludarabine | 02 | N | 330020527 | CISPLATIN + DOCETAXEL |
| 330004865 | 330002348 | null | null | Palliative (P) | null | 2016-08-20 | CNS LGG 2004 03 vinc weekly+ carbo | Y | N | 330020542 | MITOTANE |
| 330004866 | 330002349 | 0 | 112.3 | Curative (C) | null | 2013-03-18 | Doxorubicin + Olaratumab | null | null | 330020552 | CISPLATIN + FLUOROURACIL + RT |
| 330004867 | 330002350 | 1.7 | 60 | Palliative (P) | 2013-09-02 | 2015-01-17 | PEI | N | N | 330020553 | MITOTANE |
| 330004868 | 330007292 | 0 | 109.4 | Curative (C) | 2013-06-03 | 2013-06-04 | Doxorubicin chemoembolisation | 02 | N | 330020554 | AZACITIDINE |
| 330004869 | 330007292 | 1.62 | 58 | Palliative (P) | 2015-06-22 | 2015-07-26 | TEMOZOLOMIDE | N | N | 330020554 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 330004870 | 330002351 | 1.77 | 79 | null | 2017-08-04 | 2017-08-10 | UKALL14- Ph 1 Induction | N | N | 330020556 | CISPLATIN + ETOPOSIDE + RT |
| 330004871 | 330002352 | 1.75 | 89.8 | Palliative (P) | 2016-10-16 | 2016-10-17 | CISPLATIN + VINORELBINE + RT | 02 | N | 330020561 | DOCETAXEL + GEMCITABINE |
| 330004872 | 330002353 | null | 66 | Curative (C) | 2013-06-13 | 2013-06-13 | Chlorambucil | Y | N | 330020565 | BEP |
| 330004873 | 330007293 | 0 | 46.5 | null | 2016-10-25 | 2016-11-01 | Bendamustine +/- Prednisolone | null | null | 330020570 | CISPLATIN + FLUOROURACIL + RT |
| 330004874 | 330007293 | null | 91 | Curative (C) | 2014-05-18 | 2014-05-22 | Mitotane 4 - 4.5g | N | N | 330020570 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 330004875 | 330002354 | null | 85 | Palliative (P) | 2015-09-15 | 2015-10-01 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | 330020579 | CHLORAMBUCIL + RITUXIMAB |
| 330004876 | 330002354 | 0 | 90 | Adjuvant (A) | 2017-01-05 | 2017-01-11 | CARBOPLATIN + RT | 1 | Y | 330020579 | CARBOPLATIN + RT |
| 330004877 | 330002355 | 1.69 | 96.9 | Palliative (P) | 2017-05-02 | 2018-02-24 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 330020590 | CARBOPLATIN + RT |
| 330004878 | 330002355 | 0 | 88.1 | Palliative (P) | 2013-11-20 | 2013-11-21 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 330020590 | TCF |
| 330004879 | 330002355 | 1.56 | 121.9 | Disease modification (D) | 2013-12-01 | 2013-12-03 | TEMOZOLOMIDE | N | N | 330020590 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL |
| 330004880 | 330002355 | 1.66 | 99.4 | Palliative (P) | 2017-06-24 | 2017-07-28 | CHLORAMBUCIL + RITUXIMAB | N | N | 330020590 | ENZALUTAMIDE |
| 330004881 | 330002356 | 1.59 | 51.5 | Adjuvant (A) | 2015-11-02 | 2015-11-10 | AML17 TRIAL | N | N | 330020600 | CARBOPLATIN + DOCETAXEL |
| 330004882 | 330007296 | 1.61 | 12.2 | Curative (C) | 2016-10-13 | 2016-10-24 | OST Mifamurtide | N | N | 330020602 | CISPLATIN + VINORELBINE |
| 330004883 | 330009962 | 1.64 | 89.5 | Palliative (P) | 2016-03-08 | 2016-03-09 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 330020611 | CAPECITABINE + CISPLATIN |
| 330004884 | 330002357 | null | 102 | Adjuvant (A) | 2017-10-18 | 2017-10-22 | VIDE | N | N | 330020619 | CAPECITABINE + CISPLATIN |
| 330004885 | 330002357 | null | 64 | Curative (C) | 2015-02-13 | 2015-02-27 | MIFAMURTIDE | 02 | N | 330020619 | CISPLATIN + FLUOROURACIL + RT |
| 330004886 | 330002358 | 1.71 | 72.3 | Palliative (P) | null | 2016-12-31 | EDP + MITOTANE | null | null | 330020634 | CISPLATIN + DOX + ETOPOSIDE |
| 330004887 | 330007298 | null | 51.1 | Adjuvant (A) | 2013-05-16 | 2013-05-29 | Doxorubicin + Olaratumab | N | N | 330020635 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330004893 | 330011440 | null | 11.9 | Curative (C) | 2015-05-12 | 2015-05-18 | Bexarotene | 02 | N | 330020668 | AML17 TRIAL |
| 330004894 | 330012246 | 1.83 | 96 | Palliative (P) | 2017-11-25 | 2017-11-25 | BEP 5 Day | 2 | N | 330020669 | MERCAPTOPURINE |
| 330004895 | 330002360 | 0 | 65.6 | null | 2013-11-20 | 2013-11-21 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | 330020672 | HYDROXYCARBAMIDE |
| 330004896 | 330002360 | 1.81 | null | null | 2017-03-27 | 2017-03-28 | VIDE | null | null | 330020672 | TEMOZOLOMIDE + RT |
| 330004897 | 330002360 | null | null | Curative (C) | 2015-11-27 | 2015-12-10 | CYCLOPHOSPHAMIDE | Y | null | 330020672 | CARBOPLATIN + CETUXIMAB + FU |
| 330004898 | 330002361 | null | 71.4 | Palliative (P) | 2016-03-05 | 2016-04-01 | Cisplatin + Docetaxel | N | Y | 330020689 | CARBOPLATIN + GEMCITABINE + PACLITAXEL |
| 330004899 | 330002362 | null | null | Curative (C) | 2014-02-18 | 2014-02-18 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 330020693 | CARBOPLATIN + VINCRISTINE |
| 330004900 | 330007301 | 1.78 | 99.6 | Palliative (P) | null | 2015-06-13 | CVP | null | null | 330020694 | FLAG + IDARUBICIN |
| 330004901 | 330007301 | 1.71 | 90.2 | Curative (C) | 2016-09-06 | 2016-10-05 | Cisplatin + Docetaxel | N | N | 330020694 | UKALL2011 |
| 330004902 | 330011441 | null | null | Neo-adjuvant (N) | 2017-02-12 | 2017-02-13 | VIDE | N | null | 330020710 | CARBOPLATIN + RT |
| 330004904 | 330007302 | 0 | 84 | Palliative (P) | 2017-03-31 | 2017-04-01 | VIDE | N | N | 330020722 | NILOTINIB |
| 330004905 | 330007302 | 0 | 61.9 | Not known (9) | 2014-08-12 | 2014-08-12 | VIDE | N | N | 330020722 | CISPLATIN + DOCETAXEL |
| 330004906 | 330002364 | 1.75 | 90 | Adjuvant (A) | 2017-10-19 | 2017-10-31 | Temozolomide 150mg/m2 | 02 | null | 330020731 | CISPLATIN + FLUOROURACIL + RT |
| 330004907 | 330002365 | 1.73 | null | Palliative (P) | null | 2013-02-26 | CNS LGG 2004 03 vinc weekly+ carbo | null | null | 330020733 | DE-ESCALATE TRIAL |
| 330004908 | 330002365 | 1.59 | 11.9 | Curative (C) | 2017-10-31 | 2017-11-16 | GC Int Guide Excranial GermCell JEB | N | Y | 330020733 | BEP |
| 330004909 | 330002365 | null | 73 | Palliative (P) | 2015-05-13 | 2015-06-03 | TCF | N | N | 330020733 | VIDE |
| 330004910 | 330002366 | 1.56 | 56.2 | Palliative (P) | 2014-12-12 | 2014-12-23 | FLAG + Idarubicin | N | N | 330020738 | DOCETAXEL + GEMCITABINE |